Pilot trial finds acute taVNS effects on blood pressure differ by stimulation site and hypertension status
This randomized crossover pilot trial evaluated the acute effects of transcutaneous auricular vagus nerve stimulation (taVNS) on blood pressure and cardiac autonomic modulation in 14 hypertensive and 14 healthy participants. Each participant received two taVNS sessions (tragus and cymba conchae) in randomized order one week apart, with systolic BP (SBP), diastolic BP (DBP), and heart rate variability (HRV) parameters assessed at baseline, during stimulation, and post-stimulation.
Analysis revealed significant group × time × stimulation site interactions for both SBP (χ² = 19.0, p = 0.001) and DBP (χ² = 10.0, p = 0.038). Cymba conchae stimulation reduced BP in healthy individuals, while no meaningful BP changes were observed in hypertensive participants with this site. Tragus stimulation reduced diastolic BP only in the hypertensive group. Significant interactions were also detected for normalized spectral HRV components and sample entropy (p < 0.05), though responses were modest and not consistently indicative of enhanced parasympathetic modulation.
Safety and tolerability data were not reported. Key limitations include the pilot nature of the study, single-session assessment, and limited clinical impact after a single session. The authors note short-term stimulation may be insufficient to overcome impaired autonomic regulation in hypertension. These findings highlight the need for repeated or longer stimulation protocols in future clinical trials to determine if taVNS could have therapeutic potential for blood pressure management.